24.38
0.95%
+0.23
시간 외 거래:
24.38
Alkermes plc 주식(ALKS)의 최신 뉴스
Principal Financial Group Inc. Purchases 864389 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes plc (NASDAQ:ALKS) Position Decreased by BNP Paribas Financial Markets - MarketBeat
MarketBeat
Alkermes plc (NASDAQ:ALKS) Stock Holdings Lowered by BNP Paribas Financial Markets - Defense World
Defense World
(ALKS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Stock Traders Daily
Victory Capital Management Inc. Purchases 675 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Charles Schwab Investment Management Inc. Has $59.56 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Natixis Advisors L.P. Has $1.02 Million Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
The Bottom Fishing Club: Alkermes Has Great Value And Safety (NASDAQ:ALKS) - Seeking Alpha
Seeking Alpha
Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More - Yahoo New Zealand News
Yahoo New Zealand News
Russell Investments Group Ltd. Sells 81,673 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
MarketBeat
Biogen's (BIIB) Oral MS Drug Vumerity Gets Approval in Europe - Yahoo Singapore News
Yahoo Singapore News
Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences - PR Newswire
PR Newswire
Swiss National Bank Trims Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes plc (NASDAQ:ALKS) Shares Sold by Russell Investments Group Ltd. - Defense World
Defense World
Teacher Retirement System of Texas Has $12.55 Million Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
MarketBeat
Multiple insiders bought Alkermes plc (NASDAQ:ALKS) stock earlier this year, a positive sign for shareholders - Yahoo Movies Canada
Yahoo Movies Canada
Alkermes (ALKS) Beats on Q2 Earnings & Sales, Ups '21 View - Yahoo Singapore News
Yahoo Singapore News
Should You Buy Alkermes (ALKS) Ahead of Earnings? - Yahoo Movies Canada
Yahoo Movies Canada
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Canada Shine On
Yahoo Canada Shine On
Alkermes plc (NASDAQ:ALKS) Shares Purchased by Los Angeles Capital Management LLC - Defense World
Defense World
Sale of Alkermes facility in Athlone is completed - Westmeath Independent
Westmeath Independent
117,000 Shares in Alkermes plc (NASDAQ:ALKS) Purchased by LSV Asset Management - MarketBeat
MarketBeat
Fisher Asset Management LLC Buys 572 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Cwm LLC Has $55000 Stake in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
(ALKS) Technical Pivots with Risk Controls - Stock Traders Daily
Stock Traders Daily
Alkermes (ALKS) to Report Q4 Earnings: What's in Store? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals - Simply Wall St
Simply Wall St
Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved - Yahoo New Zealand News
Yahoo New Zealand News
Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved - Yahoo New Zealand News
Yahoo New Zealand News
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Singapore News
Yahoo Singapore News
BioCryst (BCRX) Wins Japanese Approval for HAE Drug Orladeyo - Yahoo Singapore News
Yahoo Singapore News
Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics - Yahoo Canada Shine On
Yahoo Canada Shine On
New York State Common Retirement Fund Buys 11747 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share - Defense World
Defense World
Brokers Offer Predictions for Alkermes plc's Q1 2025 Earnings (NASDAQ:ALKS) - MarketBeat
MarketBeat
Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share - Defense World
Defense World
GAMMA Investing LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - Defense World
Defense World
Alkermes (NASDAQ:ALKS) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 49% Undervaluation? - Yahoo Movies Canada
Yahoo Movies Canada
Alkermes Advances Narcolepsy Drug Studies - Sleep Review
Sleep Review
Alkermes Advances Narcolepsy Drug Studies - Sleep Review
Sleep Review
Alkermes (ALKS) Grants Teva License to Market Generic Drug - Yahoo Lifestyle UK
Yahoo Lifestyle UK
7 Analysts Assess Alkermes: What You Need To Know
Benzinga
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks Investment Research
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates - Zacks Investment Research
Zacks Investment Research
7 Analysts Assess Alkermes: What You Need To Know - Alkermes (NASDAQ:ALKS) - Benzinga
Benzinga
Earnings call: Alkermes reports solid Q1 2024 results, optimistic about pipeline - Investing.com
Investing.com
Yousif Capital Management LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
MarketBeat
Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
자본화:
|
볼륨(24시간):